FDA Approved: VALSARTAN — Supplemental Application (Ohm Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for VALSARTAN from Ohm Laboratories Inc. (ANDA077492).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

SUPPL AP for VALSARTAN (VALSARTAN)